Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (914)	11/19/1998 9:53:00 AM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1972

Looks like we're going to get some huge volume today :)) Scott

To: Scott H. Davis who wrote (914)	11/19/1998 3:15:00 PM
From: Jim Roof	Read Replies (1) \| Respond to of 1972

Let me see if I get this straight. VICL shows efficacy in prostate cancer and also releases news that seems at face value to be possibly ground-breaking in cancer treatment and KABOOM we get a whole point out of it? This is proof positive that fundamental information is held captive to technicals in most cases. On the positive side, the slide from mid 17's to 16 has been on decreasing volume. The supply at 16 should dry up soon and I think we are headed for the high teens in a few days. Jim